Effect of salt intake on excretion of endogenous ouabain-like substance, measured by RIA

Clinical Chemistry

Volumn 42, Issue 12, 1996, Pages 1949-1954

  Semra, Yemane K ^a   Butt, Asif N ^a   Swaminathan, R ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

ATPase; endogenous inhibitor; hypertension; potassium; sodium

Indexed keywords

ADENOSINE TRIPHOSPHATASE; DIGITALIS LIKE FACTOR; DIGITOXIN; DIGOXIN; DIHYDROOUABAIN; KEYHOLE LIMPET HEMOCYANIN; OUABAGENIN; OUABAIN; OVALBUMIN; POTASSIUM; SODIUM; STROPHANTHIDIN; TRITIUM;

ADULT; ANALYTIC METHOD; ANTIBODY TITER; ARTICLE; CROSS REACTION; DIETARY INTAKE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; IMMUNOASSAY; MALE; NORMAL HUMAN; POTASSIUM URINE LEVEL; RADIOIMMUNOASSAY; SALT INTAKE; SODIUM URINE LEVEL; URINARY EXCRETION;

CAPRA HIRCUS; DIGITALIS; STROPHANTHUS GRATUS; TRITIUM;

EID: 0029807786     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.12.1949     Document Type: Article

References (27)

1. Graves SW, Williams GH. Endogenous digitalis-like natriuretic factors. Ann Rev Med 1987;38:433-44.
2. Doris PA. Regulation of Na, K-ATPase by endogenous ouabain-like materials [Review]. Proc Soc Exp Biol Med 1994;205:202-12.
3. Yamada K, Goto A, Yagi N, Yoshioka M, Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors [Review]. Pharmacol Rev 1992;44:377-99.
4. Woolfson RG, Poston L, De Wardener HE. Digoxin-like inhibitors of active sodium transport and blood pressure: the current status. Kidney Int 1994;46:297-309.
5. Ho CS, Fung SL, Swaminathan R. The effect of salt loading on the urinary excretion of dopamine and sodium transport inhibitor in the rat. Clin Exp Hypertens 1994;16:135-46.
6. Zhao N, Lo LC, Berova N, Nakanishi K, Tymiak AA. Ludens JH, et al. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochemistry 1995;34:9893-6.
7. Shaikh IM, Lau BW, Sigfried BA, Valdes R Jr. Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex. J Biol Chem 1991;266:13672-8.
8. Hamlyn JM, Blaustein MP, Bova S, Ducharme DW, Harris DW, Mandel F, et al. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A 1991;88:6259-63.
9. Harris DW, Clark MA, Fisher JF, Hamlyn JM, Kolbasa KP, Ludens JH, et al. Development of an immunoassay for endogenous digitalislike factor. Hypertension 1991;17:936-43.
10. Doris PA, Jenkins LA, Stocco DM. Is ouabain an authentic endogenous mammalian substance derived from the adrenal? Hypertension 1994;23:632-8.
11. Lewis LK, Yandle TG, Lewis JG, Richards AM, Pidgeon GB, Kaaja RJ, et al. Ouabain is not detectable in human plasma. Hypertension 1994;24:549-55.
12. Butler VP Jr, Tse-Eng D. Immunoassay of digoxin and other cardiac glycosides. Methods Enzymol 1982;84:448-557.
13. Hamlyn JM, Manunta P, Ouabain, digitalis-like factors and hypertension. J Hypertens Suppl 1992;10:S99-111.
14. Doris PA. Ouabain in plasma from spontaneously hypertensive rats. Am J Physiol 1994;266:H360-4.
15. Naruse K, Naruse M, Tanabe A, Yoshimoto T, Watanabe Y, Kurimoto F, et al. Does plasma immunoreactive ouabain originate from the adrenal gland? Hypertension 1994;23:I102-5.
16. Komiyama Y, Mori T, Murakami T, Masuda, Takahashi H. Production of ouabain-like factors of hypothalamo-pituitary origin, determined by a sensitive ELISA for ouabain, is increased in DOCA-salt hypertensive rats. Pathophysiology 1995;2:35-40.
17. Gomez-Sanchez EP, Foecking MF, Sellers D, Blankenship MS, Gomez-Sanchez CE. Is the circulating ouabain-like compound ouabain? Am J Hypertens 1994;7:647-50.
18. Masugi F, Ogihara T, Hasegawa T, Tomii A, Nagano M, Higashimori K, et al. Circulating factor with ouabain-like immunoreactivity in patients with primary aldosteronism. Biochem Biophys Res Commun 1986;135:41-5.
19. Butt AN, Semra Y, Shepherd P, Swaminathan R. Development of an immunoassay for ouabain-like substance [Abstract]. J Hum Hypertens 1994;8:649.
20. Paci A, Ledda A, Ciarimboli G, Pascal B, Bernini GP. Commercial enzyme immunoassay reagent pack for ouabain compared with human placenta radioreceptor assay. Clin Chem 1996;42:648-50.
21. Gonick HC, Kramer HJ, Paul W, Lu E. Circulating inhibitor of sodium-potassium-activated adenosine triphosphatase after expansion of extracellular fluid volume in rats. Clin Sci Mol Med 1977;53:329-34.
22. Ludens JH, Clark MA, Kolbasa KP, Hamlyn JM. Digitalis-like factor and ouabain-like compound in plasma of volume-expanded dogs. J Cardiovasc Pharmacol 1993;22(Suppl 2):S38-41.
23. Goto A, Yamada K, Ishii M, Sugimoto T. Release of endogenous digitalis-like factor with sodium loading [Letter]. N Engl J Med 1989;320:124-5.
24. Goto A, Yamada K, Ishii M, Sugimoto T. Digitalis-like activity in human plasma: relation to blood pressure and sodium balance. Am J Med 1990;89:420-6.
25. De Wardener HE. Kidney, salt intake, and Na+,K(+)-ATPase inhibitors in hypertension. 1990 Corcoran Lecture. Hypertension 1991;17:830-6.
26. Siegfried BA, Valdes R Jr. Excretion of endogenous digoxin-like immunoreactive factors in human urine is a function of urine flow rate. Clin Chem 1988;34:960-4.
27. Semra Y, Butt AN, Swaminathan R. The effect of acute water loading on the excretion of ouabain. J Hum Hypertens 1996;[in press].